News

view more news

Epistem completes board line up and launches new NGS service

Epistem Limited, the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Investment from the Foresight group in June 2018 enabled expansion of the research services, the first of which is launched in December 2018 - GCLP compliant Next Generation Sequencing (NGS) services.

read full story

10 Years GCLP Accreditation at Epistem

We are pleased to announce the successful GCLP re-accreditation of our laboratories.

read full story

Epistem completes management buyout

Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management buy-out ("MBO") from genedrive plc.

read full story